Verastem, Inc. (VSTM)
6.86
-0.01
(-0.15%)
USD |
NASDAQ |
Nov 19, 16:00
6.86
0.00 (0.00%)
After-Hours: 20:00
Verastem Price : 6.86 for Nov. 19, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 18, 2026 | 7.35 | 7.55 | 6.78 | 6.87 | 3.977M |
| Nov 17, 2026 | 7.73 | 7.89 | 7.355 | 7.41 | 2.875M |
| Nov 16, 2026 | 8.18 | 8.30 | 7.685 | 7.70 | 2.247M |
| Nov 13, 2026 | 8.40 | 8.40 | 7.981 | 8.18 | 1.721M |
| Nov 12, 2026 | 8.84 | 9.12 | 8.41 | 8.44 | 2.089M |
| Nov 11, 2026 | 8.80 | 9.22 | 8.67 | 9.09 | 2.555M |
| Nov 10, 2026 | 8.57 | 8.81 | 8.431 | 8.73 | 2.953M |
| Nov 09, 2026 | 8.47 | 8.89 | 8.18 | 8.70 | 2.756M |
| Nov 06, 2026 | 8.66 | 8.86 | 7.72 | 8.41 | 7.038M |
| Nov 05, 2026 | 9.86 | 9.86 | 9.16 | 9.38 | 3.048M |
| Nov 04, 2026 | 10.00 | 10.10 | 9.422 | 9.85 | 2.514M |
| Nov 03, 2026 | 9.60 | 9.959 | 9.60 | 9.77 | 2.746M |
| Nov 02, 2026 | 9.60 | 9.795 | 9.50 | 9.59 | 2.113M |
| Oct 30, 2026 | 9.63 | 9.92 | 9.50 | 9.75 | 2.412M |
| Oct 29, 2026 | 9.85 | 10.03 | 9.54 | 9.66 | 1.940M |
| Oct 28, 2026 | 10.10 | 10.25 | 9.78 | 9.835 | 2.809M |
| Oct 27, 2026 | 9.945 | 10.15 | 9.76 | 10.10 | 4.708M |
| Oct 26, 2026 | 10.00 | 10.16 | 9.342 | 10.00 | 4.289M |
| Oct 23, 2026 | 10.08 | 10.22 | 9.71 | 10.04 | 3.762M |
| Oct 22, 2026 | 9.20 | 10.11 | 9.14 | 10.06 | 5.947M |
| Oct 21, 2026 | 9.41 | 9.67 | 9.12 | 9.21 | 3.062M |
| Oct 20, 2026 | 8.62 | 9.470 | 8.57 | 9.34 | 3.965M |
| Oct 19, 2026 | 8.58 | 9.17 | 8.51 | 8.62 | 3.399M |
| Oct 16, 2026 | 9.235 | 9.37 | 8.53 | 8.65 | 6.092M |
| Oct 15, 2026 | 8.04 | 9.73 | 7.77 | 9.23 | 16.96M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 43.65 |
| Cytokinetics, Inc. | 51.42 |
| Inovio Pharmaceuticals, Inc. | 1.705 |
| Rigel Pharmaceuticals, Inc. | 41.24 |
| United Therapeutics Corp. | 559.07 |
Price Related Metrics
| PS Ratio | 6.550 |
| Price to Book Value | 64.16 |
| Earnings Yield | -26.99% |
| Market Cap | 648.06M |